RNACCartesian Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Cartesian Therapeutics, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RNACEsta | $196M#3 | — | — | 490.5x#4 | -99.0%#4 | -68.3%#3 | -35851.3%#4 | — | — | — | -20.2%#2 | — |
| VNDA | $226M#1 | — | 1.1x#2 | 1.0x#1 | 8.7%#1 | -1066.7%#4 | -70.0%#2 | -110.3%#3 | — | — | -16.3%#1 | — |
| SIGA | $220M#2 | — | 1.3x#3 | 2.3x#2 | -31.8%#2 | -60.7%#2 | 25.1%#1 | 14.1%#1 | — | — | — | 19.6%#1 |
| WHWK | $176M#4 | — | 1.0x#1 | 24.7x#3 | -72.5%#3 | 67.7%#1 | -1601.1%#3 | -11.3%#2 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-03.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice